{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:59:37Z","timestamp":1790492377139,"version":"4.1.0"},"reference-count":99,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Precision medicine approaches based on pharmacogenomics are now being successfully implemented to enable physicians to predict more efficient treatments and prevention strategies for a given disease based on the genetic background of the patient. This approach has already been proposed for vaccines, but research is lagging behind the needs of society, and precision medicine is far from being implemented here. While vaccinomics concerns the effectiveness of vaccines, adversomics concerns their side effects. This area has great potential to address public concerns about vaccine safety and to promote increased public confidence, higher vaccination rates, and fewer serious adverse events in genetically predisposed individuals. The aim here is to explore the contemporary scientific literature related to the vaccinomic and adversomic aspects of the three most-controversial vaccines: those against hepatitis B, against measles, mumps, and rubella, and against human Papilloma virus. We provide detailed information on the genes that encode human leukocyte antigen, cytokines and their receptors, and transcription factors and regulators associated with the efficacy and safety of the Hepatitis B and Measles, Mumps and Rubella virus vaccines. We also investigate the future prospects of vaccinomics and adversomics of a COVID-19 vaccine, which might represent the fastest development of a vaccine ever.<\/jats:p>","DOI":"10.3390\/jcm9113561","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T09:04:34Z","timestamp":1604567074000},"page":"3561","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Vaccinomics and Adversomics in the Era of Precision Medicine: A Review Based on HBV, MMR, HPV, and COVID-19 Vaccines"],"prefix":"10.3390","volume":"9","author":[{"given":"Jasna","family":"Omersel","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, University of Ljubljana, A\u0161ker\u010deva cesta 7, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nata\u0161a","family":"Karas Ku\u017eeli\u010dki","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Ljubljana, A\u0161ker\u010deva cesta 7, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"key":"ref_1","unstructured":"(2020, September 25). Precision Medicine Initiative, Available online: https:\/\/obamawhitehouse.archives.gov\/precision-medicine."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2217\/pgs.09.25","article-title":"Application of Pharmacogenomics to Vaccines","volume":"10","author":"Poland","year":"2009","journal-title":"Pharmacogenomics"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/3934","article-title":"From Genomics to Vaccines: Malaria as a Model System","volume":"4","author":"Hoffman","year":"1998","journal-title":"Nat. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.smim.2013.04.007","article-title":"Vaccinomics, Adversomics, and the Immune Response Network Theory: Individualized Vaccinology in the 21st Century","volume":"25","author":"Poland","year":"2013","journal-title":"Semin. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1016\/j.vaccine.2017.07.062","article-title":"Personalized Vaccinology: A Review","volume":"36","author":"Poland","year":"2018","journal-title":"Vaccine"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1586\/14760584.2015.1038249","article-title":"Adversomics: A New Paradigm for Vaccine Safety and Design","volume":"14","author":"Whitaker","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.3129","article-title":"Common Variants Associated With General and MMR Vaccine\u2013Related Febrile Seizures","volume":"46","author":"Feenstra","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/473436a","article-title":"Vaccines: The Real Issues in Vaccine Safety","volume":"473","author":"Kwok","year":"2011","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/S0264-410X(00)00467-9","article-title":"Adverse Events and Vaccination-the Lack of Power and Predictability of Infrequent Events in Pre-Licensure Study","volume":"19","author":"Jacobson","year":"2001","journal-title":"Vaccine"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1473-3099(13)70238-X","article-title":"Pandemic Influenza a H1N1 Vaccines and Narcolepsy: Vaccine Safety Surveillance in Action","volume":"14","author":"Barker","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jhep.2009.01.002","article-title":"Hepatitis B Vaccination: The Key Towards Elimination and Eradication of Hepatitis B","volume":"50","author":"Chen","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.4254\/wjh.v7.i24.2503","article-title":"Recent Advances in Vaccination of Non-Responders to Standard Dose Hepatitis B Virus Vaccine","volume":"7","author":"Walayat","year":"2015","journal-title":"World J. Hepatol."},{"key":"ref_13","unstructured":"Harrison, P. (2015, January 10\u201313). Hepatitis B Vaccine Ineffective in Most Patients with RA. Proceedings of the European League Against Rheumatism (EULAR) Congress, Rome, Italy."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3748\/wjg.v19.i6.838","article-title":"Hepatitis B Vaccine in Celiac Disease: Yesterday, Today and Tomorrow","volume":"19","author":"Vitaliti","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mehy.2017.05.020","article-title":"Hepatitis B Vaccine Non Response: A Predictor of Latent Autoimmunity?","volume":"104","author":"Mormile","year":"2017","journal-title":"Med. Hypotheses"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/sj.gene.6364051","article-title":"Genetic Regulation of Immune Responses to Vaccines in Early Life","volume":"5","author":"Newport","year":"2004","journal-title":"Genes Immun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1056\/NEJM198909143211103","article-title":"Genetic Prediction of Nonresponse to Hepatitis B Vaccine","volume":"321","author":"Alper","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"ref_18","first-page":"477","article-title":"The Major Histocompatibility Complex: The Value of Extended Haplotypes in the Analysis of Associated Immune Diseases and Disorders","volume":"63","author":"Kruskall","year":"1990","journal-title":"Yale J. Boil. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(02)11083-X","article-title":"Differential Genetic Determination of Immune Responsiveness to Hepatitis B Surface Antigen and to Hepatitis a Virus: A Vaccination Study in Twins","volume":"360","author":"Reuss","year":"2002","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1399-0039.1998.tb03001.x","article-title":"Response to Hepatitis B Vaccine: Multiple HLA Genes Are Involved","volume":"51","author":"Desombere","year":"1998","journal-title":"Tissue Antigens"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2249.2005.02765.x","article-title":"Hepatitis B Surface Antigen Presentation and HLA-DRB1*\u2014Lessons from Twins and Peptide Binding Studies","volume":"140","author":"Kruger","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/gene.2010.1","article-title":"New Genetic Associations Detected in a Host Response Study to Hepatitis B Vaccine","volume":"11","author":"Davila","year":"2010","journal-title":"Genes Immun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1093\/hmg\/ddt586","article-title":"A Genome-Wide Association Study Identifies Polymorphisms in the HLA-DR Region Associated with Non-Response to Hepatitis B Vaccination in Chinese Han Populations","volume":"23","author":"Pan","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/jgh.12845","article-title":"SNP rs7770370 inHLA-DPB1 Loci as a Major Genetic Determinant of Response to Booster Hepatitis B Vaccination: Results of a Genome-Wide Association Study","volume":"30","author":"Wu","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/hep.29876","article-title":"Key HLA-DRB1-DQB1 Haplotypes and Role of the BTNL2 Gene for Response to a Hepatitis B Vaccine","volume":"68","author":"Nishida","year":"2018","journal-title":"Hepatology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0168-8278(02)00205-2","article-title":"C4 A Deficiency and Nonresponse to Hepatitis B Vaccination","volume":"37","author":"Starke","year":"2002","journal-title":"J. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.vaccine.2010.11.023","article-title":"Toll-Like Receptors and Cytokines\/Cytokine Receptors Polymorphisms Associate With Non-Response to Hepatitis B Vaccine","volume":"29","author":"Chen","year":"2011","journal-title":"Vaccine"},{"key":"ref_28","unstructured":"(2018, March 01). Ensembl. Available online: https:\/\/www.ensembl.org\/index.html."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.vaccine.2012.01.038","article-title":"Consistency of HLA Associations Between Two Independent Measles Vaccine Cohorts: A Replication Study","volume":"30","author":"Ovsyannikova","year":"2012","journal-title":"Vaccine"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1208\/s12248-011-9281-x","article-title":"Vaccinomics: Current Findings, Challenges and Novel Approaches for Vaccine Development","volume":"13","author":"Ovsyannikova","year":"2011","journal-title":"AAPS J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1542\/peds.110.1.e4","article-title":"No Evidence of Autoimmunity in 6-Year-Old Children Immunized at Birth with Recombinant Hepatitis B Vaccine","volume":"110","author":"Belloni","year":"2002","journal-title":"Pediatrics"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/08916930500095504","article-title":"HypothesisConcurrent HLA- Related Response Factors Mediate Recombinant Hepatitis B Vaccine Major Adverse Events","volume":"38","author":"Miller","year":"2005","journal-title":"Autoimmunity"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-018-0568-8","article-title":"Human Genetic Variants and Age Are the Strongest Predictors of Humoral Immune Responses to Common Pathogens and Vaccines","volume":"10","author":"Scepanovic","year":"2018","journal-title":"Genome Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1399-0039.2008.01097.x","article-title":"Associations Between Cytokine\/Cytokine Receptor Single Nucleotide Polymorphisms and Humoral Immunity to Measles, Mumps and Rubella in a Somali Population","volume":"72","author":"Dhiman","year":"2008","journal-title":"Tissue Antigens"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1084\/jem.20182295","article-title":"Inherited IFNAR1 Deficiency in Otherwise Healthy Patients With Adverse Reaction to Measles and Yellow Fever Live Vaccines","volume":"216","author":"Hernandez","year":"2019","journal-title":"J. Exp. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"307ra154","DOI":"10.1126\/scitranslmed.aac4227","article-title":"Human IFNAR2 deficiency: Lessons for antiviral immunity","volume":"7","author":"Duncan","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/FPC.0b013e32834df186","article-title":"Effects of Vitamin A and D Receptor Gene Polymorphisms\/Haplotypes on Immune Responses to Measles Vaccine","volume":"22","author":"Ovsyannikova","year":"2012","journal-title":"Pharm. Genom."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.humimm.2013.01.031","article-title":"Associations Between Polymorphisms in the Antiviral TRIM Genes and Measles Vaccine Immunity","volume":"74","author":"Ovsyannikova","year":"2013","journal-title":"Hum. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/infdis\/jix538","article-title":"Polymorphisms in the Wilms Tumor Gene Are Associated With Interindividual Variations in Rubella Virus-Specific Cellular Immunity After Measles-Mumps-Rubella II Vaccination","volume":"217","author":"Voigt","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jaip.2016.02.015","article-title":"A Novel Presentation of Homozygous Loss-of-Function STAT-1 Mutation in an Infant with Hyperinflammation\u2014A Case Report and Review of the Literature","volume":"4","author":"Burns","year":"2016","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1073\/pnas.1220098110","article-title":"STAT2 Deficiency and Susceptibility to Viral Illness in Humans","volume":"110","author":"Hambleton","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.jaci.2016.10.033","article-title":"A Novel Kindred with Inherited STAT2 Deficiency and Severe Viral Illness","volume":"139","author":"Moens","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1093\/brain\/awv182","article-title":"Signal Transducer and Activator of Transcription 2 Deficiency Is a Novel Disorder of Mitochondrial Fission","volume":"138","author":"Shahni","year":"2015","journal-title":"Brain"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1126\/science.aaa1578","article-title":"Life-Threatening Influenza and Impaired Interferon Amplification in Human IRF7 Deficiency","volume":"348","author":"Ciancanelli","year":"2015","journal-title":"Science"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1084\/jem.20180628","article-title":"Life-Threatening Influenza Pneumonitis in a Child With Inherited IRF9 Deficiency","volume":"215","author":"Hernandez","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00439-017-1768-9","article-title":"Genome-Wide Associations of CD46 and IFI44L Genetic Variants with Neutralizing Antibody Response to Measles Vaccine","volume":"136","author":"Haralambieva","year":"2017","journal-title":"Hum. Genet."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000331585","article-title":"The Association of CD46, SLAM and CD209 Cellular Receptor Gene SNPs with Variations in Measles Vaccine-Induced Immune Responses: A Replication Study and Examination of Novel Polymorphisms","volume":"72","author":"Ovsyannikova","year":"2011","journal-title":"Hum. Hered."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00439-011-0977-x","article-title":"The Role of Polymorphisms in Toll-Like Receptors and Their Associated Intracellular Signaling Genes in Measles Vaccine Immunity","volume":"130","author":"Ovsyannikova","year":"2011","journal-title":"Hum. Genet."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/S0264-410X(00)00468-0","article-title":"Twin Studies of Immunogenicity\u2014Determining the Genetic Contribution to Vaccine Failure","volume":"19","author":"Tan","year":"2001","journal-title":"Vaccine"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.vaccine.2017.01.078","article-title":"Heritability of Vaccine-Induced Measles Neutralizing Antibody Titers","volume":"35","author":"Schaid","year":"2017","journal-title":"Vaccine"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A Diverse Range of Gene Products Are Effectors of the Type I Interferon Antiviral Response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nri2378","article-title":"Vitamin Effects on the Immune System: Vitamins A and D Take Centre Stage","volume":"8","author":"Mora","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nrmicro1248","article-title":"TRIM Family Proteins: Retroviral Restriction and Antiviral Defence","volume":"3","author":"Nisole","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Haralambieva, I.H., Zimmermann, M.T., Ovsyannikova, I.G., Grill, D.E., Oberg, A.L., Kennedy, R.B., and Poland, G.A. (2016). Whole Transcriptome Profiling Identifies CD93 and Other Plasma Cell Survival Factor Genes Associated with Measles-Specific Antibody Response after Vaccination. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0160970"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Haralambieva, I.H., Kennedy, R.B., Simon, W.L., Goergen, K.M., Grill, D.E., Ovsyannikova, I.G., and Poland, G.A. (2018). Differential miRNA expression in B cells is associated with inter-individual differences in humoral immune response to measles vaccination. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0191812"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.molmed.2015.10.005","article-title":"Variability in Humoral Immunity to Measles Vaccine: New Developments","volume":"21","author":"Haralambieva","year":"2015","journal-title":"Trends Mol. Med."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Leo, P.J., Madeleine, M.M., Wang, S., Schwartz, S.M., Newell, F., Pettersson-Kymmer, U., Hemminki, K., Hallmans, G., Tiews, S., and Steinberg, W. (2017). Defining the Genetic Susceptibility to Cervical Neoplasia\u2014A Genome-Wide Association Study. PLoS Genet., 13.","DOI":"10.1371\/journal.pgen.1006866"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pvr.2018.08.001","article-title":"Variants in Immune-Related Genes and Genital HPV 16 Persistence in Men","volume":"7","author":"Mainali","year":"2019","journal-title":"Papillomavirus Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1158\/1078-0432.CCR-09-2877","article-title":"Association of TGF- Beta1 Genetic Variants with HPV16-Positive Oropharyngeal Cancer","volume":"16","author":"Guan","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6833","DOI":"10.1158\/0008-5472.CAN-14-0602-T","article-title":"TGFbeta Receptor 1: An Immune Susceptibility Gene in HPV-Associated Cancer","volume":"74","author":"Levovitz","year":"2014","journal-title":"Cancer Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3389\/fonc.2020.00548","article-title":"Personalized Human Papillomavirus Vaccination for Persistence of Immunity for Cervical Cancer Prevention: A Critical Review with Experts\u2019 Opinions","volume":"10","author":"Chambuso","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_62","unstructured":"(2020, September 25). Council for International Organisations of Medical Sciences, World Health Organisation. Available online: https:\/\/cioms.ch\/."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1542\/peds.2014-1079","article-title":"Safety of Vaccines Used for Routine Immunization of U.S. Children: A Systematic Review","volume":"134","author":"Maglione","year":"2014","journal-title":"Pediatrics"},{"key":"ref_64","unstructured":"Stratton, K. (2002). Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disordres. Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disordres, National Academic Press."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00415-016-8263-4","article-title":"Vaccines and Multiple Sclerosis: A Systematic Review","volume":"264","author":"Mailand","year":"2017","journal-title":"J. Neurol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/08830181003746304","article-title":"Could Autoimmunity Be Induced by Vaccination?","volume":"29","author":"Salemi","year":"2010","journal-title":"Int. Rev. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2249.2005.02923.x","article-title":"Anti-Phospholipid Antibodies Following Vaccination with Recombinant Hepatitis B Vaccine","volume":"142","author":"Avcin","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tox.2003.10.005","article-title":"Autoimmunity, Environmental Exposure and Vaccination: Is There a Link?","volume":"196","author":"Ravel","year":"2004","journal-title":"Toxicology"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"De Wolf, A.C.M.T., Van Aalst, S., Ludwig, I.S., Bodinham, C.L., Lewis, D.J., Van Der Zee, R., Van Eden, W., and Broere, F. (2017). Regulatory T Cell Frequencies and Phenotypes Following Anti-Viral Vaccination. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0179942"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"10369","DOI":"10.1038\/ncomms10369","article-title":"Pre-Vaccination Inflammation and B-Cell Signalling Predict Age-Related Hyporesponse to Hepatitis B Vaccination","volume":"7","author":"Fourati","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s10875-019-00642-3","article-title":"Life-Threatening Infections Due to Live-Attenuated Vaccines: Early Manifestations of Inborn Errors of Immunity","volume":"39","author":"Bustamante","year":"2019","journal-title":"J. Clin. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2041-1480-3-18","article-title":"Identification of Fever and Vaccine-Associated Gene Interaction Networks Using Ontology-Based Literature Mining","volume":"3","author":"Hur","year":"2012","journal-title":"J. Biomed. Semant."},{"key":"ref_73","unstructured":"Center for Disease Control and Prevention (2020, July 18). Human Papilloma Virus\u2014HPV Vaccination Is Safe and Effective, Available online: https:\/\/www.cdc.gov\/hpv\/parents\/vaccinesafety.html."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1177\/0961203310372952","article-title":"Are Women with Lupus at Higher Risk of HPV Infection?","volume":"19","author":"Klumb","year":"2010","journal-title":"Lupus"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/0961203311429556","article-title":"Systemic Lupus Erythematosus Following HPV Immunization or Infection?","volume":"21","author":"Soldevilla","year":"2012","journal-title":"Lupus"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.autrev.2019.02.001","article-title":"Corrigendum to \u2018Prevalence of Cervical HPV Infection in Women with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis","volume":"18","author":"Colombo","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s12026-018-9036-1","article-title":"Autonomic Dysfunction and HPV Immunization: An Overview","volume":"66","author":"Blitshteyn","year":"2018","journal-title":"Immunol. Res."},{"key":"ref_78","first-page":"211","article-title":"HPV Vaccination Syndrome: A Clinical Mirage, or a New Tragic Fibromyalgia Model","volume":"14","year":"2018","journal-title":"Reumatol. Cl\u00edn."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Ryabkova, V.A., Churilov, L.P., and Shoenfeld, Y. (2019). Neuroimmunology: What Role for Autoimmunity, Neuroinflammation, and Small Fiber Neuropathy in Fibromyalgia, Chronic Fatigue Syndrome, and Adverse Events after Human Papillomavirus Vaccination?. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20205164"},{"key":"ref_80","first-page":"S89","article-title":"Genome-Wide Expression Profiling in the Peripheral Blood of Patients with Fibromyalgia","volume":"34","author":"Jones","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_81","first-page":"1","article-title":"Carcinogenic Risk of Human Papillomavirus (HPV) Genotypes and Potential Effects of HPV Vaccines in Korea","volume":"9","author":"Park","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev-cellbio-100616-060718","article-title":"Sex and Gender Differences in the Outcomes of Vaccination over the Life Course","volume":"33","author":"Flanagan","year":"2017","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex Differences in Immune Responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/01.inf.0000145700.77286.94","article-title":"Hepatitis B Vaccination Associated with Higher Female Than Male Mortality in Guinea-Bissau: An Observational Study","volume":"23","author":"Garly","year":"2004","journal-title":"Pediatric Infect. Dis. J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"152","DOI":"10.26719\/2003.9.1-2.152","article-title":"Effect of Gender on Reporting of MMR Adverse Events in Saudi Arabia","volume":"9","author":"Khalil","year":"2003","journal-title":"East. Mediterr. Health J."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1590\/0037-8682-0109-2014","article-title":"The Prevalence of Hepatitis B Virus Infection Markers and Socio-Demographic Risk Factors in HIV-Infected Patients in Southern Brazil","volume":"47","author":"Martins","year":"2014","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jaut.2011.11.012","article-title":"The X Cromosome and Immune Associated Genes","volume":"38","author":"Bianchi","year":"2012","journal-title":"J. Autoimmun."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40246-018-0185-z","article-title":"The X Chromosome and Sex-Specific Effects in Infectious Disease Susceptibility","volume":"13","author":"Schurz","year":"2019","journal-title":"Hum. Genom."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1473-3099(10)70049-9","article-title":"The Xs and Y of Immune Responses to Viral Vaccines","volume":"10","author":"Klein","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1093\/infdis\/jiu066","article-title":"Sex-Based Biology and the Rational Design of Influenza Vaccination Strategies","volume":"209","author":"Klein","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.abc6284","article-title":"DNA Vaccine Protection Against SARS-Cov-2 in Rhesus Macaques","volume":"369","author":"Yu","year":"2020","journal-title":"Science"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","volume":"584","author":"Robbiani","year":"2020","journal-title":"Nature"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"The COVID-19 Host Genetics Initiative (2020). A Global Initiative to Elucidate the Role of Host Genetic Factors in Susceptibility and Severity of the SARS-Cov-2 Virus Pandemic. Eur. J. Hum. Genet., 28, 715\u2013718.","DOI":"10.1038\/s41431-020-0636-6"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-020-0147-1","article-title":"Comparative Genetic Analysis of the Novel Coronavirus (2019-nCov\/SARS-Cov-2) Receptor ACE2 in Different Populations","volume":"6","author":"Cao","year":"2020","journal-title":"Cell Discov."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1007\/s00277-020-04169-1","article-title":"Blood type and outcomes in patients with COVID-19","volume":"99","author":"Latz","year":"2020","journal-title":"Ann. Hematol."},{"key":"ref_96","unstructured":"Ellinghaus, D., Degenhardt, F., Bujanda, L., Buti, M., Agustin, A., Invernizzi, P., Fernandez, J., Prati, D., Baselli, G., and Asselta, R. (2020). Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N. Engl. J. Med."},{"key":"ref_97","unstructured":"(2020, October 31). The COVID-19 Sex-Disaggregated Data Tracker. Available online: https:\/\/globalhealth5050.org\/the-sex-gender-and-covid-19-project\/the-data-tracker\/."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41577-020-0348-8","article-title":"Considering How Biological Sex Impacts Immune Responses and COVID-19 Outcomes","volume":"20","author":"Scully","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Takahashi, T., Yale IMPACT Research Team, Ellingson, M.K., Wong, P., Israelow, B., Lucas, C., Klein, J., Silva, J., Mao, T., and Oh, J.E. (2020). Sex Differences in Immune Responses That Underlie COVID-19 Disease Outcomes. Nature, 1\u20139.","DOI":"10.1038\/s41586-020-2700-3"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/11\/3561\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:29:40Z","timestamp":1760178580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/11\/3561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":99,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["jcm9113561"],"URL":"https:\/\/doi.org\/10.3390\/jcm9113561","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,5]]}}}